Gastric Cancer: Generalities, Traditional Treatments and Biological Therapies as New Therapeutic Options
IAR Journal of Pharmacy · 31.01.2022 · 03 (01) · 1-13
DOI: 10.47310/iarjp.2022.v03i01.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift IAR Journal of Pharmacy, online erschienen am 31.01.2022. Verfasst von Raquel Aguilar-Murillo und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Gastric cancer is one of the most frequent types worldwide. It is the fourth most common and the second most deadly. Costa Rica is the leading country where this pathology is diagnosed in Central America. Its development involves nutritional, genetic and environmental factors, among others. Traditional treatments are based on surgery (considered first-line), radiotherapy and chemotherapy. In recent years, work has been done on new biological therapies to improve the patients' quality of life and survival. Advances have been made in the field of microRNAs, in which there is a promising future. The most studied have been MiR-218, MiR-375 and MiR-7, diminished in gastric tumors. As a complement, vaccines have been developed, including rMVHu191 and G17DT. Many have required the incorporation of adjuvants to enhance the immune response. Finally, monoclonal antibodies have been considered for distinct targets related to this disease. Of these molecules, only trastuzumab, ramucirumab, nivolumab and pembrolizumab have approval against this illness. Although there is still a long way ahead, there is the hope of more available options soon.
Zitieren
APA
Aguilar-Murillo, R., Martínez-Carpio, S., Ulloa-Rojas, R., Valerio-Villalobos, M., & Mora-Román, J. J. (2022). Gastric Cancer: Generalities, Traditional Treatments and Biological Therapies as New Therapeutic Options. IAR Journal of Pharmacy, 03(01), 1-13. https://doi.org/10.47310/iarjp.2022.v03i01.001
Vancouver
Aguilar-Murillo R, Martínez-Carpio S, Ulloa-Rojas R, Valerio-Villalobos M, Mora-Román JJ. Gastric Cancer: Generalities, Traditional Treatments and Biological Therapies as New Therapeutic Options. IAR Journal of Pharmacy. 2022;03(01):1-13. doi:10.47310/iarjp.2022.v03i01.001
BibTeX
@article{AguilarMurillo2022,
author = {Aguilar-Murillo, Raquel and Martínez-Carpio, Stefanny and Ulloa-Rojas, Raquel and Valerio-Villalobos, Melissa and Mora-Román, Juan José},
title = {Gastric Cancer: Generalities, Traditional Treatments and Biological Therapies as New Therapeutic Options},
journal = {IAR Journal of Pharmacy},
year = {2022},
volume = {03},
number = {01},
pages = {1--13},
doi = {10.47310/iarjp.2022.v03i01.001}
}
EUVIMED